Filing metadata

Accession number
0001127602-24-012884
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Apr 15, 2024
Reporting period
Apr 12, 2024
Description
Insider transaction

Explore SEC Filings Hub